Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) CEO Kim Rivers sold 136,811 shares of the business’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $8.76, for a total transaction of $1,198,464.36. Following the completion of the sale, the chief executive officer directly owned 1,476,913 shares of the company’s stock, valued at $12,937,757.88. This represents a 8.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trulieve Cannabis Stock Up 4.8%
Shares of TRLV traded up $0.41 during mid-day trading on Friday, hitting $8.93. 1,586,171 shares of the company’s stock were exchanged, compared to its average volume of 584,527. Trulieve Cannabis Corp. has a 52 week low of $3.50 and a 52 week high of $13.28.
Analysts Set New Price Targets
Several analysts recently issued reports on TRLV shares. Weiss Ratings started coverage on shares of Trulieve Cannabis in a research report on Tuesday, June 16th. They set a “sell (d-)” rating on the stock. Zacks Research upgraded Trulieve Cannabis to a “hold” rating in a research note on Thursday, June 18th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Reduce”.
Trulieve Cannabis Company Profile
Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.
Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.
Featured Articles
- Five stocks we like better than Trulieve Cannabis
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
